Risk factors associated with response to highly active antiretroviral therapy after 24 months of administration to HIV, HIV/HBV and HCV patients in Kumba Health District, South West Region of Cameroon
<p>Hepatitis B (HBV) and C (HCV) are two other forms of infections for which co-infection in HIV has been associated with alteration of the immune response, increased risk of progression to liver diseases, and increased risk of hepatotoxicity associated with antiretroviral therapy. This study...
Saved in:
Main Authors: | Adamu Ndongho Ndifontiayong (Author), Innocent Mbulli Ali (Author), Jean Baptiste Sokoudjou (Author), Karimo Ousenu (Author), Jerimiah Ndimumeh Mbogwe (Author), Ousenu Karimo (Author), Christopher Bonglavnyuy Tume (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2022-09-26.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of malaria parasitemia in people living with HIV/AIDS in Kumba, Cameroon
by: Eyong Clinton Achere, et al.
Published: (2022) -
Sero-prevalence of Hepatitis B and C virus and High Risk of Hepatotoxicity among TB/HIV Positive and HIV Negative Population in Western Cameroon
by: Leonard Fonkeng Sama, et al.
Published: (2017) -
IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
by: Ingrid Rodríguez-Alonso, et al.
Published: (2016) -
HIV Infection in the Era of Highly Active Antiretroviral Treatment and Some of Its Associated Complications
Published: (2011) -
Evaluation of the Therapeutic Efficacy of Antiretroviral Drugs used in the Clinical Management of HIV/AIDS Infection
by: Anochie PI, et al.
Published: (2015)